Cargando…
Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction
BACKGROUND: Myocardial ischaemia–reperfusion injury is a major cause of mortality and morbidity in the developed world. Many approaches have been investigated to counteract the pathological consequences associated with acute myocardial infarction (AMI) and cardiac remodelling. It is accepted that in...
Autores principales: | Clark, James, E, Dudler, Thomas, Marber, Michael, S, Schwaeble, Wilhelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761301/ https://www.ncbi.nlm.nih.gov/pubmed/29344374 http://dx.doi.org/10.1136/openhrt-2017-000652 |
Ejemplares similares
-
Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1
por: Orsini, Franca, et al.
Publicado: (2016) -
p38 MAPK in cardioprotection – are we there yet?
por: Martin, E D, et al.
Publicado: (2015) -
Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk
por: Horne, Benjamin D, et al.
Publicado: (2018) -
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023) -
Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine–prothrombin complex antibody
por: Yamada, Mai, et al.
Publicado: (2017)